Associate Professor, Geriatrics, University of Arkansas COM
Endocrinology
Dr. Donald Bodenner, MD
|
|
Give Review
Donald Bodenner, MD works in the field of Endocrinology. He studied medicine at University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Donald Bodenner is a published physician. He published 45 publications, including: 'Thyroid disease mediated by molecular defects in cell surface and nuclear receptors.' Dr. Donald Bodenner accepts all Medicare patients.
Publications
- Preoperative 4D CT Localization of Nonlocalizing ParaThyroid Adenomas by Ultrasound and SPECT-CT.
- Barriers to Same-Day Discharge of Patients Undergoing Total and Completion Thyroidectomy.
- Costs of Outpatient Thyroid Surgery from the University HealthSystem Consortium (UHC) Database.
- Conservative management of thyroglobulin-positive, nonlocalizable Thyroid carcinoma.
- Characterization of hyperparaThyroidism in youth and adolescents: A literature review.
- Outpatient Thyroid Surgery Data from the University Health System (UHC) Consortium.
- Thyroid incidentalomas on FDG-PET may be more significant than other incidentally discovered Thyroid nodules.
- Outpatient ParaThyroid Surgery Data from the University Health System Consortium.
- Metastatic Follicular Thyroid Carcinoma Secreting Thyroid Hormone and Radioiodine Avid without Stimulation: A Case Report and Literature Review.
- Acute lysine supplementation does not improve hepatic or peripheral insulin sensitivity in older, overweight individuals.
- Vitamin D deficiency: A simple algorithm employing weekly administration of 50,000IU of vitamin D.
- Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.
- Thyroid disease mediated by molecular defects in cell surface and nuclear receptors.
- Binding of Type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro.
- Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to Thyroid hormone.
- Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to Thyroid hormone.
- An AP-1-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate hormonal induction of human thyrotropin beta gene expression.
- A c-fos/c-jun-like factor and the pituitary-specific factor Pit-1 are both necessary to mediate induction of the human thyrotropin beta promoter.
- Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
- Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
- A detailed functional and structural analysis of a major Thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene.
- The proto-oncogenes c-fos and c-jun modulate Thyroid hormone inhibition of human thyrotropin beta subunit gene expression in opposite directions.
- Fine-needle aspiration diagnosis of Thyroid blastomycosis.
- Teriparatide in the management of osteoporosis.
- Methylation status of genes in papillary Thyroid carcinoma.
- Incidence of Thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive Thyroid incidentalomas.
- A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents With clinically significant weight loss.
- Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D.
- Considerations in incorporating office-based ultrasound of the head and neck.
- Effects of megestrol acetate on pituitary function and end-organ hormone secretion: a post hoc analysis of serum samples from a 12-week study in healthy older men.
- Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation.
- HypoThyroidism in patients with multiple myeloma following treatment with thalidomide.
- Delayed Treatment of Papillary Thyroid Carcinoma Arising from Struma Ovarii in a Patient with History of Bilateral Salpingooophorectomy: A Case Report.
- 18F-fluorodeoxyglucose and 131I Radioguided Surgical Management of Thyroid Cancer.
- Incidence of diffuse FDG uptake in the Thyroid of patients with hypoThyroidism.
- Markedly elevated serum calcitonin concentrations associated with initial presentation but not the recurrent presentation of medullary Thyroid carcinoma.
- ParaThyroid carcinoma.
- A study of resident proficiency with Thyroid surgery: creation of a Thyroid-specific tool.
- Intraoperative radiation exposure with the use of (18)F-FDG-guided Thyroid cancer surgery.
- Diagnostic and surgical dilemmas in hereditary medullary Thyroid carcinoma.
- Role of vitamin D deficiency in continued hyperparaThyroidism following paraThyroidectomy.
- Visceral fat and adiponectin: associations With insulin resistance are tissue-specific in women.
- The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in Obesity.
- Lingual Thyroid: iodine 131: a viable treatment modality revisited.
Schools
Univ Of Mn Med Sch
Clinical Center At The Nih
University Of Mn Affil Hosps
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
University of Minnesota Medical School
Drug Facts
| NPI NUMBER | 1427148998 | |
| NPPES Provider LastName | BODENNER | |
| NPPES Provider FirstName | DONALD | |
| NPPES Provider ZIPCode | 722057101 | |
| NPPES Provider State | AR | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1770.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 0.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427148998 |
| Last Name Of The Provider | BODENNER |
| First Name Of The Provider | DONALD |
| View All |
Similar Doctors
|
|
Dr. Shunzhong S. Bao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawson E. Glover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond L. Marecek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen H. Redding, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maher Alesali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Castro Bali, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Archana Jarathi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Thrasher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena Ambrogini, MD
This Doctor is OpenDoctor Recommended.
|